| Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease C Teng, C Lin, F Huang, X Xing, S Chen, L Ye, HS Azevedo, C Xu, Z Wu, ... Acta Pharmaceutica Sinica B 10 (8), 1521-1533, 2020 | 51 | 2020 |
| Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension C Teng, B Li, C Lin, X Xing, F Huang, Y Yang, Y Li, HS Azevedo, W He Journal of Controlled Release 341, 591-604, 2022 | 33 | 2022 |
| Molecular perspective of efficiency and safety problems of chemical enhancers: bottlenecks and recent advances L Zeng, F Huang, Q Zhang, J Liu, D Quan, W Song Drug Delivery and Translational Research, 1-19, 2022 | 24 | 2022 |
| COVID-19 inflammation and implications in drug delivery M Zoulikha, F Huang, Z Wu, W He Journal of Controlled Release 346, 260-274, 2022 | 23 | 2022 |
| A nanocrystal platform based on metal-phenolic network wrapping for drug solubilization F Huang, X Jiang, MA Sallam, X Zhang, W He AAPS PharmSciTech 23 (3), 76, 2022 | 11 | 2022 |
| Pulmonary endothelium-targeted nanoassembly of indomethacin and superoxide dismutase relieves lung inflammation Y Yang, M Zoulikha, Q Xiao, F Huang, Q Jiang, X Li, Z Wu, W He Acta Pharmaceutica Sinica B 13 (11), 4607-4620, 2023 | 8 | 2023 |